UBS Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-25,005
| Closed | -$95K | – | 7563 |
|
|
2020
Q1 | $95K | Sell |
25,005
-44,678
| -64% | -$170K | ﹤0.01% | 4478 |
|
|
2019
Q4 | $355K | Sell |
69,683
-95,057
| -58% | -$484K | ﹤0.01% | 4177 |
|
|
2019
Q3 | $833K | Buy |
164,740
+82,609
| +101% | +$418K | ﹤0.01% | 3327 |
|
|
2019
Q2 | $507K | Buy |
82,131
+43,011
| +110% | +$266K | ﹤0.01% | 3541 |
|
|
2019
Q1 | $181K | Sell |
39,120
-232,527
| -86% | -$1.08M | ﹤0.01% | 3908 |
|
|
2018
Q4 | $1.14M | Buy |
271,647
+264,601
| +3,755% | +$1.11M | ﹤0.01% | 2880 |
|
|
2018
Q3 | $44K | Buy |
7,046
+2,997
| +74% | +$18.7K | ﹤0.01% | 5363 |
|
|
2018
Q2 | $33K | Sell |
4,049
-113,995
| -97% | -$929K | ﹤0.01% | 5416 |
|
|
2018
Q1 | $880K | Buy |
118,044
+115,197
| +4,046% | +$859K | ﹤0.01% | 3124 |
|
|
2017
Q4 | $17K | Sell |
2,847
-23,200
| -89% | -$139K | ﹤0.01% | 5726 |
|
|
2017
Q3 | $192K | Buy |
26,047
+14,229
| +120% | +$105K | ﹤0.01% | 4034 |
|
|
2017
Q2 | $80K | Sell |
11,818
-132
| -1% | -$894 | ﹤0.01% | 4426 |
|
|
2017
Q1 | $113K | Sell |
11,950
-31,387
| -72% | -$297K | ﹤0.01% | 4141 |
|
|
2016
Q4 | $375K | Buy |
43,337
+14,261
| +49% | +$123K | ﹤0.01% | 3505 |
|
|
2016
Q3 | $184K | Sell |
29,076
-13,070
| -31% | -$82.7K | ﹤0.01% | 3785 |
|
|
2016
Q2 | $178K | Buy |
42,146
+25,596
| +155% | +$108K | ﹤0.01% | 3818 |
|
|
2016
Q1 | $72K | Sell |
16,550
-111,221
| -87% | -$484K | ﹤0.01% | 4447 |
|
|
2015
Q4 | $783K | Buy |
127,771
+111,971
| +709% | +$686K | ﹤0.01% | 2851 |
|
|
2015
Q3 | $90K | Buy |
15,800
+8,700
| +123% | +$49.6K | ﹤0.01% | 4286 |
|
|
2015
Q2 | $53K | Buy |
7,100
+2,000
| +39% | +$14.9K | ﹤0.01% | 4747 |
|
|
2015
Q1 | $31K | Sell |
5,100
-300
| -6% | -$1.82K | ﹤0.01% | 5027 |
|
|
2014
Q4 | $41K | Buy |
+5,400
| New | +$41K | ﹤0.01% | 4899 |
|